{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T08:11:06Z","timestamp":1784103066151,"version":"3.55.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2012,3,24]],"date-time":"2012-03-24T00:00:00Z","timestamp":1332547200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s00262-012-1245-1","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T15:33:18Z","timestamp":1332516798000},"page":"1833-1847","source":"Crossref","is-referenced-by-count":49,"title":["CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapy"],"prefix":"10.1007","volume":"61","author":[{"given":"Sivan","family":"Sapoznik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rona","family":"Ortenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilli","family":"Galore-Haskel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stav","family":"Kozlovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphna","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Avivi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Barshack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrille J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal J.","family":"Besser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Schachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gal","family":"Markel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,24]]},"reference":[{"key":"1245_CR1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1359-6101(01)00033-8","volume":"13","author":"AP Vicari","year":"2002","unstructured":"Vicari AP, Caux C (2002) Chemokines in cancer. Cytokine Growth Factor Rev 13:143\u2013154","journal-title":"Cytokine Growth Factor Rev"},{"key":"1245_CR2","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-08-2281","volume":"69","author":"H Harlin","year":"2009","unstructured":"Harlin H, Meng Y, Peterson AC, Zha Y, Tretiakova M et al (2009) Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. Cancer Res 69:3077\u20133085","journal-title":"Cancer Res"},{"key":"1245_CR3","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.2741\/3158","volume":"13","author":"A Viola","year":"2008","unstructured":"Viola A, Molon B, Contento RL (2008) Chemokines: coded messages for T-cell missions. Front Biosci 13:6341\u20136353","journal-title":"Front Biosci"},{"key":"1245_CR4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc1388","volume":"4","author":"F Balkwill","year":"2004","unstructured":"Balkwill F (2004) Cancer and the chemokine network. Nat Rev Cancer 4:540\u2013550","journal-title":"Nat Rev Cancer"},{"key":"1245_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2008.06.017","volume":"44","author":"T Jin","year":"2008","unstructured":"Jin T, Xu X, Hereld D (2008) Chemotaxis, chemokine receptors and human disease. Cytokine 44:1","journal-title":"Cytokine"},{"key":"1245_CR6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/eji.200526208","volume":"36","author":"T Zhang","year":"2006","unstructured":"Zhang T, Somasundaram R, Berencsi K, Caputo L, Gimotty P et al (2006) Migration of cytotoxic T lymphocytes toward melanoma cells in three-dimensional organotypic culture is dependent on CCL2 and CCR4. Eur J Immunol 36:457\u2013467","journal-title":"Eur J Immunol"},{"key":"1245_CR7","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/(SICI)1096-9896(199912)189:4<552::AID-PATH469>3.0.CO;2-I","volume":"189","author":"M Kunz","year":"1999","unstructured":"Kunz M, Toksoy A, Goebeler M, Engelhardt E, Brocker E et al (1999) Strong expression of the lymphoattractant C-X-C chemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma. J Pathol 189:552\u2013558","journal-title":"J Pathol"},{"key":"1245_CR8","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.4049\/jimmunol.174.9.5856","volume":"174","author":"T Zhang","year":"2005","unstructured":"Zhang T, Somasundaram R, Berencsi K, Caputo L, Rani P et al (2005) CXC Chemokine Ligand 12 (Stromal Cell-Derived Factor 1-\u00b1) and CXCR4-Dependent Migration of CTLs toward Melanoma Cells in Organotypic Culture. J Immunol 174:5856","journal-title":"J Immunol"},{"key":"1245_CR9","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.4049\/jimmunol.176.5.2902","volume":"176","author":"F Vianello","year":"2006","unstructured":"Vianello F, Papeta N, Chen T, Kraft P, White N et al (2006) Murine B16 Melanomas Expressing High Levels of the Chemokine Stromal-Derived Factor-1\/CXCL12 Induce Tumor-Specific T Cell Chemorepulsion and Escape from Immune Control. J Immunol 176:2902","journal-title":"J Immunol"},{"key":"1245_CR10","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1200\/JCO.2008.16.5449","volume":"26","author":"ME Dudley","year":"2008","unstructured":"Dudley ME, Yang JC, Sherry R, Hughes MS, Royal R et al (2008) Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens. J Clin Oncol 26:5233","journal-title":"J Clin Oncol"},{"key":"1245_CR11","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1200\/JCO.2005.00.240","volume":"23","author":"ME Dudley","year":"2005","unstructured":"Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL et al (2005) Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 23:2346\u20132357","journal-title":"J Clin Oncol"},{"key":"1245_CR12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrc2355","volume":"8","author":"SA Rosenberg","year":"2008","unstructured":"Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME (2008) Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer 8:299\u2013308","journal-title":"Nat Rev Cancer"},{"key":"1245_CR13","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1200\/JCO.2006.07.1100","volume":"24","author":"A Mackensen","year":"2006","unstructured":"Mackensen A, Meidenbauer N, Vogl S, Laumer M, Berger J et al (2006) Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma. J Clin Oncol 24:5060\u20135069","journal-title":"J Clin Oncol"},{"key":"1245_CR14","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1038\/jid.2009.144","volume":"129","author":"A Khammari","year":"2009","unstructured":"Khammari A, Labarriere N, Vignard V, Nguyen JM, Pandolfino MC et al (2009) Treatment of metastatic melanoma with autologous Melan-A\/MART-1-specific cytotoxic T lymphocyte clones. J Invest Dermatol 129:2835\u20132842","journal-title":"J Invest Dermatol"},{"key":"1245_CR15","doi-asserted-by":"crossref","unstructured":"Brimnes MK, Gang AO, Donia M, Thor Straten P, Svane IM, et al. (2012) Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3\/CD28 dynabead-induced T cell expansion. Cancer Immunol Immunother","DOI":"10.1007\/s00262-011-1199-8"},{"key":"1245_CR16","doi-asserted-by":"crossref","first-page":"7125","DOI":"10.4049\/jimmunol.173.12.7125","volume":"173","author":"PF Robbins","year":"2004","unstructured":"Robbins PF, Dudley ME, Wunderlich J, El-Gamil M, Li YF et al (2004) Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy. J Immunol 173:7125\u20137130","journal-title":"J Immunol"},{"key":"1245_CR17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00002371-200501000-00007","volume":"28","author":"J Zhou","year":"2005","unstructured":"Zhou J, Dudley ME, Rosenberg SA, Robbins PF (2005) Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy. J Immunother 28:53\u201362","journal-title":"J Immunother"},{"key":"1245_CR18","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1200\/JCO.2003.12.144","volume":"21","author":"AC Peterson","year":"2003","unstructured":"Peterson AC, Harlin H, Gajewski TF (2003) Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma. J Clin Oncol 21:2342\u20132348","journal-title":"J Clin Oncol"},{"key":"1245_CR19","first-page":"37","volume":"3","author":"JN Cormier","year":"1997","unstructured":"Cormier JN, Salgaller ML, Prevette T, Barracchini KC, Rivoltini L et al (1997) Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1\/Melan A. Cancer J Sci Am 3:37\u201344","journal-title":"Cancer J Sci Am"},{"key":"1245_CR20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/annonc\/mdj138","volume":"17","author":"D Schadendorf","year":"2006","unstructured":"Schadendorf D, Ugurel S, Schuler-Thurner B, Nestle FO, Enk A et al (2006) Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. Ann Oncol 17:563\u2013570","journal-title":"Ann Oncol"},{"key":"1245_CR21","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.4049\/jimmunol.175.9.6169","volume":"175","author":"SA Rosenberg","year":"2005","unstructured":"Rosenberg SA, Sherry RM, Morton KE, Scharfman WJ, Yang JC et al (2005) Tumor progression can occur despite the induction of very high levels of self\/tumor antigen-specific CD8\u00a0+\u00a0T cells in patients with melanoma. J Immunol 175:6169\u20136176","journal-title":"J Immunol"},{"key":"1245_CR22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1129003","volume":"314","author":"RA Morgan","year":"2006","unstructured":"Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC et al (2006) Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314:126\u2013129","journal-title":"Science"},{"key":"1245_CR23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1182\/blood-2009-03-211714","volume":"114","author":"LA Johnson","year":"2009","unstructured":"Johnson LA, Morgan RA, Dudley ME, Cassard L, Yang JC et al (2009) Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood 114:535\u2013546","journal-title":"Blood"},{"key":"1245_CR24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.coi.2009.03.002","volume":"21","author":"SA Rosenberg","year":"2009","unstructured":"Rosenberg SA, Dudley ME (2009) Adoptive cell therapy for the treatment of patients with metastatic melanoma. Curr Opin Immunol 21:233\u2013240","journal-title":"Curr Opin Immunol"},{"key":"1245_CR25","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1158\/1078-0432.CCR-10-0712","volume":"16","author":"W Peng","year":"2010","unstructured":"Peng W, Ye Y, Rabinovich BA, Liu C, Lou Y et al (2010) Transduction of tumor-specific T cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responses. Clin Cancer Res 16:5458\u20135468","journal-title":"Clin Cancer Res"},{"key":"1245_CR26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1200\/JCO.1989.7.2.250","volume":"7","author":"B Fisher","year":"1989","unstructured":"Fisher B, Packard BS, Read EJ, Carrasquillo JA, Carter CS et al (1989) Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma. J Clin Oncol 7:250\u2013261","journal-title":"J Clin Oncol"},{"key":"1245_CR27","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1158\/1078-0432.CCR-07-0892","volume":"13","author":"TF Gajewski","year":"2007","unstructured":"Gajewski TF (2007) Failure at the effector phase: immune barriers at the level of the melanoma tumor microenvironment. Clin Cancer Res 13:5256\u20135261","journal-title":"Clin Cancer Res"},{"key":"1245_CR28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1600-065X.2006.00442.x","volume":"213","author":"TF Gajewski","year":"2006","unstructured":"Gajewski TF, Meng Y, Blank C, Brown I, Kacha A et al (2006) Immune resistance orchestrated by the tumor microenvironment. Immunol Rev 213:131","journal-title":"Immunol Rev"},{"key":"1245_CR29","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2567.2008.02888.x","volume":"126","author":"G Markel","year":"2009","unstructured":"Markel G, Seidman R, Cohen Y, Besser MJ, Sinai TC et al (2009) Dynamic expression of protective CEACAM1 on melanoma cells during specific immune attack. Immunology 126:186\u2013200","journal-title":"Immunology"},{"key":"1245_CR30","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1158\/1078-0432.CCR-10-0041","volume":"16","author":"MJ Besser","year":"2010","unstructured":"Besser MJ, Shapira-Frommer R, Treves AJ, Zippel D, Itzhaki O et al (2010) Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients. Clin Cancer Res 16:2646\u20132655","journal-title":"Clin Cancer Res"},{"key":"1245_CR31","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.4049\/jimmunol.177.9.6062","volume":"177","author":"G Markel","year":"2006","unstructured":"Markel G, Seidman R, Stern N, Cohen-Sinai T, Izhaki O et al (2006) Inhibition of human tumor-infiltrating lymphocyte effector functions by the homophilic carcinoembryonic cell adhesion molecule 1 interactions. J Immunol 177:6062\u20136071","journal-title":"J Immunol"},{"key":"1245_CR32","doi-asserted-by":"crossref","unstructured":"Markel G, Ortenberg R, Seidman R, Sapoznik S, Koren-Morag N, et al. (2010) Systemic dysregulation of CEACAM1 in melanoma patients. Cancer Immunol Immunother 59(2):215\u2013230","DOI":"10.1007\/s00262-009-0740-5"},{"key":"1245_CR33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2613.2009.00698.x","volume":"91","author":"J Svec","year":"2010","unstructured":"Svec J, Ergang P, Mandys V, Kment M, Pacha J (2010) Expression profiles of proliferative and antiapoptotic genes in sporadic and colitis-related mouse colon cancer models. Int J Exp Pathol 91:44\u201353","journal-title":"Int J Exp Pathol"},{"key":"1245_CR34","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1089\/10430340252939087","volume":"13","author":"PJ Orchard","year":"2002","unstructured":"Orchard PJ, Blazar BR, Burger S, Levine B, Basso L et al (2002) Clinical-scale selection of anti-CD3\/CD28-activated T cells after transduction with a retroviral vector expressing herpes simplex virus thymidine kinase and truncated nerve growth factor receptor. Hum Gene Ther 13:979\u2013988","journal-title":"Hum Gene Ther"},{"key":"1245_CR35","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.4049\/jimmunol.0902047","volume":"184","author":"G Bialer","year":"2010","unstructured":"Bialer G, Horovitz-Fried M, Ya\u2019acobi S, Morgan RA, Cohen CJ (2010) Selected murine residues endow human TCR with enhanced tumor recognition. J Immunol 184:6232\u20136241","journal-title":"J Immunol"},{"key":"1245_CR36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ymthe.2005.07.688","volume":"13","author":"Y Zhao","year":"2006","unstructured":"Zhao Y, Zheng Z, Cohen CJ, Gattinoni L, Palmer DC et al (2006) High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation. Mol Ther 13:151\u2013159","journal-title":"Mol Ther"},{"key":"1245_CR37","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/CJI.0b013e31819c8bda","volume":"32","author":"MJ Besser","year":"2009","unstructured":"Besser MJ, Shapira-Frommer R, Treves AJ, Zippel D, Itzhaki O et al (2009) Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients. J Immunother 32:415\u2013423","journal-title":"J Immunother"},{"key":"1245_CR38","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.4049\/jimmunol.1000225","volume":"185","author":"S Eikawa","year":"2010","unstructured":"Eikawa S, Ohue Y, Kitaoka K, Aji T, Uenaka A et al (2010) Enrichment of Foxp3+ CD4 regulatory T cells in migrated T cells to IL-6- and IL-8-expressing tumors through predominant induction of CXCR1 by IL-6. J Immunol 185:6734\u20136740","journal-title":"J Immunol"},{"key":"1245_CR39","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1089\/10430340260355374","volume":"13","author":"MH Kershaw","year":"2002","unstructured":"Kershaw MH, Wang G, Westwood JA, Pachynski RK, Tiffany HL et al (2002) Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2. Hum Gene Ther 13:1971\u20131980","journal-title":"Hum Gene Ther"},{"key":"1245_CR40","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1182\/blood-2004-03-1067","volume":"104","author":"C Hess","year":"2004","unstructured":"Hess C, Means TK, Autissier P, Woodberry T, Altfeld M et al (2004) IL-8 responsiveness defines a subset of CD8 T cells poised to kill. Blood 104:3463\u20133471","journal-title":"Blood"},{"key":"1245_CR41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bbi.2008.10.005","volume":"23","author":"EV Yang","year":"2009","unstructured":"Yang EV, Kim SJ, Donovan EL, Chen M, Gross AC et al (2009) Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun 23:267\u2013275","journal-title":"Brain Behav Immun"},{"key":"1245_CR42","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1182\/blood.V90.11.4588","volume":"90","author":"A Ludwig","year":"1997","unstructured":"Ludwig A, Petersen F, Zahn S, Gotze O, Schroder JM et al (1997) The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2. Blood 90:4588\u20134597","journal-title":"Blood"},{"key":"1245_CR43","doi-asserted-by":"crossref","first-page":"30000","DOI":"10.1074\/jbc.M313883200","volume":"279","author":"L Rajagopalan","year":"2004","unstructured":"Rajagopalan L, Rajarathnam K (2004) Ligand selectivity and affinity of chemokine receptor CXCR1. Role of N-terminal domain. J Biol Chem 279:30000\u201330008","journal-title":"J Biol Chem"},{"key":"1245_CR44","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1182\/blood-2005-04-1366","volume":"106","author":"O Gasser","year":"2005","unstructured":"Gasser O, Missiou A, Eken C, Hess C (2005) Human CD8+ T cells store CXCR1 in a distinct intracellular compartment and up-regulate it rapidly to the cell surface upon activation. Blood 106:3718\u20133724","journal-title":"Blood"},{"key":"1245_CR45","doi-asserted-by":"crossref","first-page":"8806","DOI":"10.4049\/jimmunol.177.12.8806","volume":"177","author":"O Gasser","year":"2006","unstructured":"Gasser O, Schmid TA, Zenhaeusern G, Hess C (2006) Cyclooxygenase regulates cell surface expression of CXCR3\/1-storing granules in human CD4+ T cells. J Immunol 177:8806\u20138812","journal-title":"J Immunol"},{"key":"1245_CR46","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.4049\/jimmunol.1000225","volume":"185","author":"S Eikawa","year":"2010","unstructured":"Eikawa S, Ohue Y, Kitaoka K, Aji T, Uenaka A et al (2010) Enrichment of Foxp3+ CD4 regulatory T cells in migrated T cells to IL-6- and IL-8-expressing tumors through predominant induction of CXCR1 by IL-6. J Immunol 185:6734\u20136740","journal-title":"J Immunol"},{"key":"1245_CR47","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1128\/JVI.75.7.3462-3468.2001","volume":"75","author":"T Shioda","year":"2001","unstructured":"Shioda T, Nakayama EE, Tanaka Y, Xin X, Liu H et al (2001) Naturally occurring deletional mutation in the C-terminal cytoplasmic tail of CCR5 affects surface trafficking of CCR5. J Virol 75:3462\u20133468","journal-title":"J Virol"},{"key":"1245_CR48","first-page":"295","volume":"17","author":"G Quereux","year":"2007","unstructured":"Quereux G, Pandolfino MC, Knol AC, Khammari A, Volteau C et al (2007) Tissue prognostic markers for adoptive immunotherapy in melanoma. Eur J Dermatol 17:295\u2013301","journal-title":"Eur J Dermatol"},{"key":"1245_CR49","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.4049\/jimmunol.170.4.2161","volume":"170","author":"N Meidenbauer","year":"2003","unstructured":"Meidenbauer N, Marienhagen J, Laumer M, Vogl S, Heymann J et al (2003) Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients. J Immunol 170:2161\u20132169","journal-title":"J Immunol"},{"key":"1245_CR50","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jcb.240360209","volume":"36","author":"A Richmond","year":"1988","unstructured":"Richmond A, Thomas HG (1988) Melanoma growth stimulatory activity: isolation from human melanoma tumors and characterization of tissue distribution. J Cell Biochem 36:185\u2013198","journal-title":"J Cell Biochem"},{"key":"1245_CR51","first-page":"4932","volume":"60","author":"EK Rofstad","year":"2000","unstructured":"Rofstad EK, Halsor EF (2000) Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. Cancer Res 60:4932\u20134938","journal-title":"Cancer Res"},{"key":"1245_CR52","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s10038-006-0021-5","volume":"51","author":"HS Cheong","year":"2006","unstructured":"Cheong HS, Shin HD, Lee SO, Park BL, Choi YH et al (2006) Polymorphisms in interleukin 8 and its receptors (IL8, IL8RA and IL8RB) and association of common IL8 receptor variants with peripheral blood eosinophil counts. J Hum Genet 51:781","journal-title":"J Hum Genet"},{"key":"1245_CR53","first-page":"159","volume":"34","author":"D Dumitrascu","year":"1996","unstructured":"Dumitrascu D (1996) Mast cells as potent inflammatory cells. Rom J Intern Med 34:159\u2013172","journal-title":"Rom J Intern Med"},{"key":"1245_CR54","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.4049\/jimmunol.153.12.5682","volume":"153","author":"A Chuntharapai","year":"1994","unstructured":"Chuntharapai A, Lee J, Hebert CA, Kim KJ (1994) Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. J Immunol 153:5682\u20135688","journal-title":"J Immunol"},{"key":"1245_CR55","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1182\/blood.V97.2.367","volume":"97","author":"M Inngjerdingen","year":"2001","unstructured":"Inngjerdingen M, Damaj B, Maghazachi AA (2001) Expression and regulation of chemokine receptors in human natural killer cells. Blood 97:367\u2013375","journal-title":"Blood"},{"key":"1245_CR56","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1084\/jem.20040424","volume":"200","author":"ML Smith","year":"2004","unstructured":"Smith ML, Olson TS, Ley K (2004) CXCR2- and E-selectin-induced neutrophil arrest during inflammation in vivo. J Exp Med 200:935\u2013939","journal-title":"J Exp Med"},{"key":"1245_CR57","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1158\/1078-0432.CCR-10-0712","volume":"16","author":"W Peng","year":"2010","unstructured":"Peng W, Ye Y, Rabinovich BA, Liu C, Lou Y et al (2010) Transduction of tumor-specific T Cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responses. Clin Cancer Res 16:5458\u20135468","journal-title":"Clin Cancer Res"},{"key":"1245_CR58","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.1882","volume":"14","author":"MA Pule","year":"2008","unstructured":"Pule MA, Savoldo B, Myers GD, Rossig C, Russell HV et al (2008) Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma. Nat Med 14:1264\u20131270","journal-title":"Nat Med"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-012-1245-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-012-1245-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-012-1245-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T10:58:04Z","timestamp":1687345084000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-012-1245-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,24]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["1245"],"URL":"https:\/\/doi.org\/10.1007\/s00262-012-1245-1","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,24]]}}}